Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations

Cancer Discovery
Sumanta K PalDean F Bajorin

Abstract

BGJ398, a potent and selective pan-FGFR antagonist, was prospectively evaluated in patients with metastatic urothelial carcinoma bearing a diverse array of FGFR3 alterations. Patients (N = 67) who were unable to receive platinum chemotherapy were enrolled. The majority (70.1%) had received two or more prior antineoplastic therapies. BGJ398 was administered orally at 125 mg/day on a 3 weeks on, 1 week off schedule until unacceptable toxicity or progression. The primary endpoint was the response rate. Among 67 patients treated, an overall response rate of 25.4% was observed and an additional 38.8% of patients had disease stabilization, translating to a disease control rate of 64.2%. The most common treatment-emergent toxicities were hyperphosphatemia, elevated creatinine, fatigue, constipation, and decreased appetite. Further examination of BGJ398 in this disease setting is warranted.Significance: BJG398 is active in patients with alterations in FGFR3, resulting in both reductions in tumor volume and stabilization of disease. Our data highlight putative mechanisms of resistance to the agent, which may be useful in following disease status. Cancer Discov; 8(7); 812-21. ©2018 AACR.This article is highlighted in the In This Issue fe...Continue Reading

References

Jan 11, 2000·Nucleic Acids Research·S T SherryK Sirotkin
May 1, 2012·Nature Biotechnology·Scott L CarterGad Getz
Feb 12, 2013·Nature Biotechnology·Kristian CibulskisGad Getz
Feb 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey S DamrauerWilliam Y Kim
Oct 31, 2014·Nucleic Acids Research·Simon A ForbesPeter J Campbell
Dec 3, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Matthew I MilowskyCora N Sternberg
Jun 17, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mehdi TouatJean-Charles Soria
May 20, 2016·Cancer Immunology Research·Randy F SweisThomas F Gajewski
Jun 9, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christophe MassardNeil H Segal
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sumanta Kumar PalElizabeth R Plimack
Dec 22, 2016·Source Code for Biology and Medicine·Markus RiesterMichael P Morrissey
Feb 18, 2017·The New England Journal of Medicine·Joaquim BellmuntUNKNOWN KEYNOTE-045 Investigators
Mar 4, 2017·Molecular Cancer Therapeutics·Jharna DattaSameek Roychowdhury
Apr 5, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea B ApoloJames L Gulley

❮ Previous
Next ❯

Citations

Nov 10, 2018·Expert Opinion on Pharmacotherapy·Aly-Khan A Lalani, Guru P Sonpavde
Dec 19, 2018·Expert Opinion on Therapeutic Targets·Kyrillus S ShohdyBishoy M Faltas
Jan 4, 2019·The Journal of Pathology·Gottfrid SjödahlDavid M Berman
Mar 8, 2019·Current Opinion in Oncology·Omar AlhalabiJianjun Gao
Jul 25, 2019·The New England Journal of Medicine·Yohann LoriotUNKNOWN BLC2001 Study Group
Nov 2, 2019·Acta Clinica Belgica·Stijn De KeukeleireSylvie Rottey
Oct 17, 2019·Nature·William A FlavahanBradley E Bernstein
Dec 8, 2019·Expert Review of Clinical Pharmacology·Kamaneh Montazeri, Joaquim Bellmunt
Nov 7, 2019·Minerva urologica e nefrologica = The Italian journal of urology and nephrology·Cosimo De NunzioAlessia Brigido
Mar 27, 2020·Current Opinion in Oncology·Omar AlhalabiJianjun Gao
Mar 7, 2020·ESMO Open·Elizabeth Liow, Ben Tran
May 29, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Young K ChaeKeith T Flaherty
May 22, 2020·Expert Review of Anticancer Therapy·Qian QinMatthew D Galsky
Jun 18, 2020·Expert Review of Anticancer Therapy·Rohit K Jain, Guru Sonpavde
Jul 16, 2020·The Korean Journal of Internal Medicine·Inkeun Park, Jae Lyun Lee
Sep 6, 2019·Journal of Hematology & Oncology·Kevin ZarrabiShenhong Wu
Jun 30, 2019·Current Treatment Options in Oncology·Petros Grivas, Evan Y Yu
Sep 24, 2019·Expert Review of Anticancer Therapy·Laura MarandinoAndrea Necchi
Dec 6, 2019·Therapeutic Advances in Medical Oncology·Chiara CasadeiUgo De Giorgi
Apr 3, 2020·Nature Reviews. Urology·Joshua J MeeksLars Dyrskjøt
Apr 25, 2020·Cancers·Valentina GambardellaAndres Cervantes
Oct 18, 2018·International Journal of Molecular Sciences·Se Hyun KimSun Young Rha
Mar 14, 2020·Current Urology Reports·Tuomas JalankoPeter C Black
Aug 9, 2020·CA: a Cancer Journal for Clinicians·Vaibhav G PatelMatthew D Galsky
Sep 29, 2020·F1000Research·Chelsea K Osterman, Matthew I Milowsky
Nov 15, 2018·Cancers·Francesca MusumeciSilvia Schenone
Dec 24, 2018·Therapeutic Advances in Urology·Alfonso Gómez De Liaño, Ignacio Duran
Nov 14, 2018·World Journal of Urology·Damiano Fantini, Joshua J Meeks
May 3, 2019·Prostate Cancer and Prostatic Diseases·Melanie A KrookSameek Roychowdhury
May 18, 2019·American Society of Clinical Oncology Educational Book·Petros GrivasGuru Sonpavde
May 27, 2020·Current Opinion in Urology·Iris E ErtlYohann Loriot
May 8, 2020·American Society of Clinical Oncology Educational Book·Andrew L SchmidtBradley McGregor
Apr 5, 2019·Cell Proliferation·Xiaodiao KangZhi-Wei Wang
Dec 14, 2018·World Journal of Urology·David J McConkey, Seth P Lerner
Dec 24, 2018·Nature Reviews. Urology·Min Yuen Teo, Jonathan E Rosenberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.